News from Endovascular TodayFollowNews from Endovascular TodayAll of today’s top news stories from Endovascular Today. Get the full analysis behind how media bias impacts breaking news.In total, 15 have been published by Endovascular Today which Ground News has aggregated in the past 3 months. Endovascular Today’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Endovascular Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.Follow All of today’s top news stories from Endovascular Today. Get the full analysis behind how media bias impacts breaking news. In total, 15 have been published by Endovascular Today which Ground News has aggregated in the past 3 months. Endovascular Today’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Endovascular Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check. Information about Endovascular TodayWhere is Endovascular Today located?Endovascular Today's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top Endovascular Today NewsSan Francisco, California · San FranciscoIceCure’s ProSense Cryoablation System’s Benefit-Risk Profile for Breast Cancer Indications Reviewed by FDA Panel - Endovascular TodayNovember 25, 2024—IceCure Medical Ltd. recently announced the FDA Medical Device Advisory Committee Panel’s favorable recommendation (voting, 9-5) of the benefit-risk profile of the company’s ProSense cryoablation system for the proposed indications of the treatment of patients with early-stage, low-risk invasive breast cancer with cryoablation and adjuvant endocrine therapy. The FDA’s decision on marketing authorization is expected in the first…See the StoryLatest News StoriesTopics Most Covered by Endovascular TodayHealthFDAHealthFDASources Covering Similar TopicsInterventional NewsCardiac Interventions TodayBusiness UpturnGilbert Sun NewsInterventional NewsCardiac Interventions TodayBusiness UpturnSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
